Display options
Cite
Borzooy Z, Jazayeri SM, Mirshafiey A, et al. Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination. Germs. 2015;5(4):134-40doi: 10.11599/germs.2015.1081.
Borzooy, Z., Jazayeri, S. M., Mirshafiey, A., Khamseh, A., Mahmoudie, M. K., Azimzadeh, P., Geravand, B., Boroumand, M. A., Afshar, M., Poortahmasebi, V., Hosseini, M., & Streinu-Cercel, A. (2015). Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination. Germs, 5(4), 134-40. https://doi.org/10.11599/germs.2015.1081
Borzooy, Zohreh, et al. "Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination." Germs vol. 5,4 (2015): 134-40. doi: https://doi.org/10.11599/germs.2015.1081
Borzooy Z, Jazayeri SM, Mirshafiey A, Khamseh A, Mahmoudie MK, Azimzadeh P, Geravand B, Boroumand MA, Afshar M, Poortahmasebi V, Hosseini M, Streinu-Cercel A. Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination. Germs. 2015 Dec 02;5(4):134-40. doi: 10.11599/germs.2015.1081. eCollection 2015 Dec. PMID: 26716102; PMCID: PMC4691194.
Copy Download .nbib Format: NLM
Share it on

Germs. 2015 Dec 02;5(4):134-40. doi: 10.11599/germs.2015.1081. eCollection 2015 Dec.

Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination.

Germs

Zohreh Borzooy, Seyed Mohammad Jazayeri, Abbass Mirshafiey, Azam Khamseh, Masoud Karkhaneh Mahmoudie, Pedram Azimzadeh, Babak Geravand, Mohammad Ali Boroumand, Mina Afshar, Vahdat Poortahmasebi, Mostafa Hosseini, Adrian Streinu-Cercel

Affiliations

  1. PhD student, Ms, Department of Infectious Diseases, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Department of Immunology and Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  2. MD, PhD, Clinical virologist, Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  3. Ms, PhD, Head of the Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  4. Bs, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  5. Ms, Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  6. Ms, Ministry of Health and Medical Education, Tehran, Iran.
  7. MD, Pathologist, Department of Pathology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  8. Bs, Tehran University of Medical Sciences, Mirza Kouchak Khan Hospital, Tehran, Iran.
  9. Ms, PhD student, Virologist, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  10. Ms, PhD, Department of Epidemiology and Biostatistics School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  11. MD, PhD, Professor, Department of Infectious Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; National Institute of Infectious Diseases, "Prof. Dr. Matei Bal?", Bucharest, Romania.

PMID: 26716102 PMCID: PMC4691194 DOI: 10.11599/germs.2015.1081

Abstract

BACKGROUND: Worldwide, healthcare workers (HCWs) show different levels of response to hepatitis B virus (HBV) vaccine. One of the factors associated with vaccine unresponsiveness may be the existence of current or past HBV infection. Regardless of the presence of HBsAg (overt infection), occult HBV infection (OBI, defined as presence of HBV DNA in the absence of HBsAg) might also account for some non- or hypo-response cases.

METHODS: Sera from 120 HBsAg-negative HCWs with low and moderate levels of anti-HBs, <10 IU/mL (group I) and <100 IU/mL (group II) respectively, were selected and were examined for OBI by sensitive real-time PCR regardless of HBV serological profiles. Direct sequencing on surface genes was carried out in OBI-positive cases.

RESULTS: Four (3.3%) were positive for OBI. All were negative for anti-HBc. Two of the positive cases had moderate levels of anti-HBs (>10 to <100 IU/mL). No significant differences were found between the two groups in terms of risk factors or serological data. No mutations were found in surface proteins of OBI cases.

CONCLUSION: OBI in these subjects might be due to other factors rather than presence of "a" determinant mutations. Healthcare workers with inadequate to moderate levels of anti-HBs (<100 IU/mL) following vaccination, regardless of their serological profile for HBV, should be tested for the presence of HBV DNA by sensitive molecular tests. Anti-HBc is not a reliable marker for suspicion of OBI, especially in high-risk group individuals.

Keywords: HBV; HBV vaccine; Healthcare workers; hepatitis B virus

References

  1. Vaccine. 2007 Feb 26;25(10 ):1848-55 - PubMed
  2. Vaccine. 2004 Sep 9;22(27-28):3789-96 - PubMed
  3. Hum Immunol. 1997 Nov;58(1):42-51 - PubMed
  4. Semin Liver Dis. 2003 Feb;23(1):39-46 - PubMed
  5. Gastroenterology. 2002 Oct;123(4):1084-9 - PubMed
  6. J Gastroenterol Hepatol. 2008 Nov;23(11):1710-5 - PubMed
  7. Hepatology. 2000 Feb;31(2):507-12 - PubMed
  8. Eur J Gastroenterol Hepatol. 2008 Feb;20(2):131-4 - PubMed
  9. Przegl Epidemiol. 2012;66(3):445-51 - PubMed
  10. Int J Prev Med. 2012 Nov;3(11):770-5 - PubMed
  11. Vaccine. 2012 Jun 8;30(27):4034-9 - PubMed
  12. Vaccine. 2011 Feb 11;29(8):1721-6 - PubMed
  13. Germs. 2012 Dec 01;2(4):137-41 - PubMed
  14. J Hepatol. 2009 Feb;50(2):426-31 - PubMed
  15. Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):831-8 - PubMed
  16. Liver Int. 2005 Dec;25(6):1162-8 - PubMed
  17. JAMA. 1993 Dec 22-29;270(24):2931-4 - PubMed
  18. Hepat Mon. 2011 Feb;11(2):99-102 - PubMed
  19. J Occup Environ Med. 2002 Jun;44(6):591-6 - PubMed
  20. Hepat Mon. 2012 Aug;12(8):e6126 - PubMed
  21. Int J Occup Med Environ Health. 2003;16(3):249-53 - PubMed
  22. Ann Intern Med. 2005 Mar 1;142(5):333-41 - PubMed
  23. Minerva Gastroenterol Dietol. 2012 Jun;58(2):167-78 - PubMed
  24. Arch Iran Med. 2006 Jul;9(3):204-7 - PubMed
  25. Int J Occup Environ Med. 2011 Oct;2(4):191-8 - PubMed
  26. Am J Ind Med. 2005 Dec;48(6):482-90 - PubMed
  27. J Hepatol. 2012 Sep;57(3):515-21 - PubMed
  28. Lancet. 1990 Aug 11;336(8711):325-9 - PubMed
  29. J Gastrointestin Liver Dis. 2007 Dec;16(4):403-6 - PubMed
  30. Infection. 2009 Jun;37(3):266-9 - PubMed
  31. J Med Virol. 1996 Dec;50(4):283-8 - PubMed
  32. J Hepatol. 2008 Oct;49(4):652-7 - PubMed
  33. Am J Infect Control. 2002 Feb;30(1):15-20 - PubMed
  34. Antiviral Res. 2001 Nov;52(2):117-23 - PubMed
  35. Hepat Mon. 2015 Apr 25;15(5):e23618 - PubMed
  36. Vaccine. 2010 Sep 7;28(39):6411-6 - PubMed

Publication Types